Chokri Ben Lamine: Drinks and Hematology – What Matters Clinically?
Chokri Ben Lamine, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on X:
“Drinks and Hematology: what matters clinically?
Alcohol
- Heavy use can cause macrocytosis, with or without anemia, leukopenia and thrombocytopenia
- Mechanisms: direct marrow toxicity, folate deficiency, liver disease and hypersplenism
- Impairs platelet function, so bleeding may occur despite an acceptable count
- Avoid with severe thrombocytopenia, mucositis, liver disease, iron overload, anticoagulation or hepatotoxic chemotherapy
- Dehydration may precipitate sickle-cell vaso-occlusive crisis
Tea and coffee
- Tannins and polyphenols reduce non-heme iron absorption
- Keep a 2-hour gap from oral iron and iron-rich meals
- They do not cause iron deficiency alone but may impair correction when intake is marginal
Orange juice
- Vitamin C can improve oral iron absorption
- Not essential if iron is tolerated and responding
Calcium-fortified juice can markedly reduce eltrombopag absorption.
Milk and dairy drinks
- Reduce absorption of oral iron
- With eltrombopag (Revolade and Promacta): take eltrombopag at least 2 hours before or at least 4 hours after dairy, calcium-fortified drinks, antacids or mineral supplements.
Grapefruit juice
Inhibits intestinal CYP3A/P-glycoprotein, leading to increased drug exposure and toxicity
Avoid with:
- Venetoclax (Venclexta)—also avoid Seville oranges and starfruit
- Ibrutinib (Imbruvica)
- Tacrolimus (Prograf)
- Sirolimus (Rapamune)
- Several TKIs and other oral anticancer agents—always check the individual label
Green tea and extracts
- Ordinary intake reduces iron absorption when taken with meals
- High-dose epigallocatechin gallate supplements may antagonize bortezomib (Velcade) in preclinical studies; clinical relevance is uncertain, but concentrated extracts are best avoided during bortezomib therapy.
Tonic water
- Contains quinine
- Rarely causes severe drug-induced immune thrombocytopenia, hemolysis or thrombotic microangiopathy
Permanent avoidance after suspected quinine-associated thrombocytopenia—even small re-exposure may trigger rapid recurrence.
Green smoothies
- Vitamin K-rich ingredients do not need to be eliminated with warfarin (Coumadin)
Keep intake consistent and monitor INR after major dietary changes.
Energy drinks
- No hematinic or platelet-raising benefit
- High caffeine may worsen tachycardia, tremor and dehydration-related symptoms – particularly poorly tolerated with severe anemia or cardiotoxic therapy.
Water
- Dehydration causes relative erythrocytosis and may worsen hyperviscosity, AKI, tumor lysis syndrome and sickle-cell complications
- During venetoclax initiation/ramp-up: approximately 1.5–2 L/day, starting 2 days beforehand, unless cardiac/renal fluid restriction requires an individualized plan.
Neutropenia and HSCT
Avoid unpasteurized juice, raw milk and unsafe water
Use pasteurized products and safe drinking water.
MCQ: A patient taking eltrombopag drinks it with milk. Expected effect?
- Increased thrombosis
- Reduced eltrombopag absorption
- Increased hepatotoxicity
- No interaction
OSCE pearl: Always ask specifically about alcohol, grapefruit, tonic water, tea and coffee timing, energy drinks, herbal beverages and fortified juices—patients rarely classify these as ‘medications.’
Sources: NIAAA—alcohol-related hematologic effects, NIH MedlinePlus—oral iron, Eltrombopag prescribing information, FDA venetoclax label, FDA tacrolimus label, Blood—green tea/bortezomib study.”
Other posts featuring Chokri Ben Lamine on Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome